Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nick S. Berrow is active.

Publication


Featured researches published by Nick S. Berrow.


Nucleic Acids Research | 2007

A versatile ligation-independent cloning method suitable for high-throughput expression screening applications

Nick S. Berrow; David Alderton; Sarah Sainsbury; Joanne E. Nettleship; René Assenberg; Nahid Rahman; David I. Stuart; Raymond J. Owens

This article describes the construction of a set of versatile expression vectors based on the In-Fusion™ cloning enzyme and their use for high-throughput cloning and expression screening. Modifications to commonly used vectors rendering them compatible with In-Fusion™ has produced a ligation-independent cloning system that is (1) insert sequence independent (2) capable of cloning large PCR fragments (3) efficient over a wide (20-fold) insert concentration range and (4) applicable to expression in multiple hosts. The system enables the precise engineering of (His6-) tagged constructs with no undesirable vector or restriction-site-derived amino acids added to the expressed protein. The use of a multiple host-enabled vector allows rapid screening in both E. coli and eukaryotic hosts (HEK293T cells and insect cell hosts, e.g. Sf9 cells). These high-throughput screening activities have prompted the development and validation of automated protocols for transfection of mammalian cells and Ni-NTA protein purification.


Acta Crystallographica Section D-biological Crystallography | 2005

A procedure for setting up high-throughput nanolitre crystallization experiments. Crystallization workflow for initial screening, automated storage, imaging and optimization

Thomas S. Walter; Jonathan M. Diprose; C.J. Mayo; Christian Siebold; M.G. Pickford; Lester G. Carter; Geoffrey C. Sutton; Nick S. Berrow; James Brown; Ian Berry; Guillaume Stewart-Jones; Jonathan M. Grimes; David K. Stammers; Robert M. Esnouf; E.Y. Jones; Raymond J. Owens; David I. Stuart; Karl Harlos

Crystallization trials at the Division of Structural Biology in Oxford are now almost exclusively carried out using a high‐throughput workflow implemented in the Oxford Protein Production Facility. Initial crystallization screening is based on nanolitre‐scale sitting‐drop vapour‐diffusion experiments (typically 100 nl of protein plus 100 nl of reservoir solution per droplet) which use standard crystallization screening kits and 96‐well crystallization plates. For 294 K crystallization trials the barcoded crystallization plates are entered into an automated storage system with a fully integrated imaging system. These plates are imaged in accordance with a pre‐programmed schedule and the resulting digital data for each droplet are harvested into a laboratory information‐management system (LIMS), scored by crystal recognition software and displayed for user analysis via a web‐based interface. Currently, storage for trials at 277 K is not automated and for imaging the crystallization plates are fed by hand into an imaging system from which the data enter the LIMS. The workflow includes two procedures for nanolitre‐scale optimization of crystallization conditions: (i) a protocol for variation of pH, reservoir dilution and protein:reservoir ratio and (ii) an additive screen. Experience based on 592 crystallization projects is reported.


Structure | 2004

The nsp9 replicase protein of SARS-coronavirus, structure and functional insights.

Geoff Sutton; Elizabeth E. Fry; Lester G. Carter; Sarah Sainsbury; Thomas S. Walter; Joanne E. Nettleship; Nick S. Berrow; Raymond J. Owens; Robert J. C. Gilbert; Andrew D. Davidson; Stuart G. Siddell; Leo L.M. Poon; Jonathan M. Diprose; David Alderton; Martin A. Walsh; Jonathan M. Grimes; David I. Stuart

As part of a high-throughput structural analysis of SARS-coronavirus (SARS-CoV) proteins, we have solved the structure of the non-structural protein 9 (nsp9). This protein, encoded by ORF1a, has no designated function but is most likely involved with viral RNA synthesis. The protein comprises a single β-barrel with a fold previously unseen in single domain proteins. The fold superficially resembles an OB-fold with a C-terminal extension and is related to both of the two subdomains of the SARS-CoV 3C-like protease (which belongs to the serine protease superfamily). nsp9 has, presumably, evolved from a protease. The crystal structure suggests that the protein is dimeric. This is confirmed by analytical ultracentrifugation and dynamic light scattering. We show that nsp9 binds RNA and interacts with nsp8, activities that may be essential for its function(s).


Acta Crystallographica Section D-biological Crystallography | 2006

Implementation of semi-automated cloning and prokaryotic expression screening: the impact of SPINE

Pedro M. Alzari; H. Berglund; Nick S. Berrow; Elena Blagova; Didier Busso; Christian Cambillau; Valérie Campanacci; Evangelos Christodoulou; S. Eiler; Mark J. Fogg; Gert E. Folkers; Arie Geerlof; Darren J. Hart; Ahmed Haouz; Maria Dolores Herman; S. Macieira; Pär Nordlund; Anastassis Perrakis; Sophie Quevillon-Cheruel; F. Tarandeau; H. van Tilbeurgh; Tamar Unger; Mark P.A. Luna-Vargas; M. Velarde; M. Willmanns; Raymond J. Owens

The implementation of high-throughput (HTP) cloning and expression screening in Escherichia coli by 14 laboratories in the Structural Proteomics In Europe (SPINE) consortium is described. Cloning efficiencies of greater than 80% have been achieved for the three non-ligation-based cloning techniques used, namely Gateway, ligation-indendent cloning of PCR products (LIC-PCR) and In-Fusion, with LIC-PCR emerging as the most cost-effective. On average, two constructs have been made for each of the approximately 1700 protein targets selected by SPINE for protein production. Overall, HTP expression screening in E. coli has yielded 32% soluble constructs, with at least one for 70% of the targets. In addition to the implementation of HTP cloning and expression screening, the development of two novel technologies is described, namely library-based screening for soluble constructs and parallel small-scale high-density fermentation.


Journal of Biological Chemistry | 2007

The Structure and Transcriptional Analysis of a Global Regulator from Neisseria meningitidis

Jingshan Ren; Sarah Sainsbury; Susan E. Combs; Richard G. Capper; Philip W. Jordan; Nick S. Berrow; David K. Stammers; Nigel J. Saunders; Raymond J. Owens

Neisseria meningitidis, a causative agent of bacterial meningitis, has a relatively small repertoire of transcription factors, including NMB0573 (annotated AsnC), a member of the Lrp-AsnC family of regulators that are widely expressed in both Bacteria and Archaea. In the present study we show that NMB0573 binds to l-leucine and l-methionine and have solved the structure of the protein with and without bound amino acids. This has shown, for the first time that amino acid binding does not induce significant conformational changes in the structure of an AsnC/Lrp regulator although it does appear to stabilize the octameric assembly of the protein. Transcriptional profiling of wild-type and NMB0573 knock-out strains of N. meningitidis has shown that NMB0573 is associated with an adaptive response to nutrient poor conditions reflected in a reduction in major surface protein expression. On the basis of its structure and the transcriptional response, we propose that NMB0573 is a global regulator in Neisseria controlling responses to nutrient availability through indicators of general amino acid abundance: leucine and methionine.


Methods of Molecular Biology | 2009

The Precise Engineering of Expression Vectors Using High-Throughput In-Fusion™ PCR Cloning

Nick S. Berrow; David Alderton; Raymond J. Owens

In this chapter, protocols for the construction of expression vectors using In-Fusion PCR cloning are presented. The method enables vector and insert DNA sequences to be seamlessly joined in a ligation-independent reaction. This property of the In-Fusion process has been exploited in the design of a suite of multi-host compatible vectors for the expression of proteins with precisely engineered His-tags. Vector preparation, PCR amplification of the sequence to be cloned and the procedure for inserting the PCR product into the vector by In-Fusion are described.


Protein Expression and Purification | 2008

A pipeline for the production of antibody fragments for structural studies using transient expression in HEK 293T cells

Joanne E. Nettleship; Jingshan Ren; Nahid Rahman; Nick S. Berrow; Deborah Hatherley; A. Neil Barclay; Raymond J. Owens

We describe a pipeline for the rapid production of recombinant Fabs derived from mouse monoclonal antibodies suitable for use in structural studies. The pipeline is exemplified by the production of three Fabs derived from the monoclonal antibodies OX108 (anti-CD200 receptor), OX117 and OX119 (anti-SIRPgamma). Heavy and light chain variable domains were inserted into separate expression vectors containing resident constant regions using In-Fusion PCR cloning. Following transient co-expression in HEK 293T cells, secreted Fab fragments were purified by metal chelate chromatography and gel filtration using an automated procedure with yields of up to 4mg/L of cell culture. Following crystallization trials, diffracting crystals were obtained for the recombinant Fabs of OX108 and OX117, and their structures solved to 2.3A and 2.4A, respectively.


BMC Structural Biology | 2005

Crystal structure of nitrogen regulatory protein IIANtr from Neisseria meningitidis

Jingshan Ren; Sarah Sainsbury; Nick S. Berrow; David Alderton; Joanne E. Nettleship; David K. Stammers; Nigel J. Saunders; Raymond J. Owens

BackgroundThe NMB0736 gene of Neisseria meningitidis serogroup B strain MC58 encodes the putative nitrogen regulatory protein, IIANtr (abbreviated to NM-IIANtr). The homologous protein present in Escherichia coli is implicated in the control of nitrogen assimilation. As part of a structural proteomics approach to the study of pathogenic Neisseria spp., we have selected this protein for structure determination by X-ray crystallography.ResultsThe NM-IIANtr was over-expressed in E. coli and was shown to be partially mono-phosphorylated, as assessed by mass spectrometry of the purified protein.Crystals of un-phosphorylated protein were obtained and diffraction data collected to 2.5 Å resolution. The structure of NM-IIANtr was solved by molecular replacement using the coordinates of the E. coli nitrogen regulatory protein IIAntr [PDB: 1A6J] as the starting model. The overall fold of the Neisseria enzyme shows a high degree of similarity to the IIANtr from E. coli, and the position of the phosphoryl acceptor histidine residue (H67) is conserved. The orientation of an adjacent arginine residue (R69) suggests that it may also be involved in coordinating the phosphate group. Comparison of the structure with that of E. coli IIAmtl complexed with HPr [PDB: 1J6T] indicates that NM-IIANtr binds in a similar way to the HPr-like enzyme in Neisseria.ConclusionThe structure of NM-IIANtr confirms its assignment as a homologue of the IIANtr proteins found in a range of other Gram-negative bacteria. We conclude that the NM- IIANtr protein functions as part of a phosphorylation cascade which, in contrast to E. coli, shares the upstream phosphotransfer protein with the sugar uptake phosphoenolpyruvate:sugar phosphotransferase system (PTS), but in common with E. coli has a distinct downstream effector mechanism.


Proteins | 2007

Crystal Structure of a 3-Oxoacyl-(Acylcarrier Protein) Reductase (Ba3989) from Bacillus Anthracis at 2.4-A Resolution.

Nathan R. Zaccai; Lester G. Carter; Nick S. Berrow; Sarah Sainsbury; Joanne E. Nettleship; Thomas S. Walter; Karl Harlos; Raymond J. Owens; Keith S. Wilson; David I. Stuart; Robert M. Esnouf

Crystal structure of a 3-oxoacyl-(acyl carrier protein) reductase (BA3989) from Bacillus anthracis at 2.4-Å resolution Nathan R. Zaccai, Lester G. Carter, Nick S. Berrow, Sarah Sainsbury, Joanne E. Nettleship, Thomas S. Walter, Karl Harlos, Ray J. Owens, Keith S. Wilson, David I. Stuart, and Robert M. Esnouf* 1 The Oxford Protein Production Facility, Division of Structural Biology, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, United Kingdom 2York Structural Biology Laboratory, Department of Chemistry, University of York, Heslington, York YO10 5YW, United Kingdom


Acta Crystallographica Section F-structural Biology and Crystallization Communications | 2006

Structure of the PII signal transduction protein of Neisseria meningitidis at 1.85 Å resolution

Charles E. Nichols; Sarah Sainsbury; Nick S. Berrow; David Alderton; Nigel J. Saunders; David K. Stammers; Raymond J. Owens

The P(II) signal transduction proteins GlnB and GlnK are implicated in the regulation of nitrogen assimilation in Escherichia coli and other enteric bacteria. P(II)-like proteins are widely distributed in bacteria, archaea and plants. In contrast to other bacteria, Neisseria are limited to a single P(II) protein (NMB 1995), which shows a high level of sequence identity to GlnB and GlnK from Escherichia coli (73 and 62%, respectively). The structure of the P(II) protein from N. meningitidis (serotype B) has been solved by molecular replacement to a resolution of 1.85 A. Comparison of the structure with those of other P(II) proteins shows that the overall fold is tightly conserved across the whole population of related proteins, in particular the positions of the residues implicated in ATP binding. It is proposed that the Neisseria P(II) protein shares functions with GlnB/GlnK of enteric bacteria.

Collaboration


Dive into the Nick S. Berrow's collaboration.

Top Co-Authors

Avatar

Raymond J. Owens

Rutherford Appleton Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joanne E. Nettleship

Rutherford Appleton Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

David K. Stammers

Wellcome Trust Centre for Human Genetics

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Karl Harlos

Wellcome Trust Centre for Human Genetics

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge